Hideki Tomioka, Ph.D. is the CSO of FunPep Co., Ltd..  He currently leads an active pipeline of chronic disease immunotherapeutic candidates including for Psoriasis, Ankylosing spondylitis and Pollinosis. He graduated from Graduate School of Pharmaceutical Sciences, Tokyo University of Science in March 1997.  He was employed in Ono Pharmaceutical Co., Ltd. from 1997 to 2005. He worked as a researcher at AnGes MG, Inc. from 2005 to 2015. He received his Ph.D from Graduate School of Medicine, Osaka University in 2014.  He joined FunPep Co., Ltd.in 2015. His research interests the functional peptides.